All The Latest Research
A2 Milk (ASX:A2M) is Looking Fundamentally Cheap and Poised for Daigou Recovery
Today we will look at why we think A2 Milk shares (ASX:A2M) having been sold off so heavily may now present an opportunity. We'll also go through some analysis of our A2M share price forecast. A2 Milk Company Ltd (ASX:A2M) has been a stock market darling over the past...
BHP (ASX:BHP) is a Long term, High Dividend Yield Play on Commodities and Positive Global Macroeconomic Trends
Today we will look at why we like BHP shares (ASX:BHP) as a dividend play along with some analysis on our BHP share price forecast. We first wrote about BHP back in March 2018, when the price was about $29. Since then, at the time of writing, the BHP share price is...
MoneyMe (ASX:MME) is a Profitable Fintech Play and First Mover in Auto Financing
Today we will look at why we like MoneyMe shares (ASX:MME) and some analysis on our MME share price forecast. MoneyMe (ASX:MME) is an Australian financial technology company that provides an array of lending services. The company’s AI-enabled procedures for fast and...
Webjet (ASX:WEB) Well-Positioned to Leverage COVID Recovery In Travel
Today we will look at why we think Webjet shares (ASX:WEB) are a good buy and some analysis on our WEB share price forecast. Webjet Limited (ASX:WEB) is a digital travel services provider that acts as an intermediary in the B2B travel accommodation market. It also...
Nanosonics (ASX:NAN) to Benefit from COVID Normalisation and Market Expansion
Today we will look at why we like Nanosonics shares (ASX:NAN) and some analysis on our NAN share price forecast. Nanosonics is a producer of HLD (High-Level Disinfection) medical equipment. The company’s products are mainly used in the disinfection of ultrasound...
Race Oncology (ASX:RAC) is a Potential Acquisition Target in a $530B M&A Market
Today we will take a look at why we like Race Oncology shares (ASX:RAC) and whether the RAC share price is worth buying at the moment. Race Oncology (ASX:RAC) is a precision oncology company with a phase II/III cancer drug called Bisantrene. The aim of the company is...
Megaport (ASX:MP1) is a High Growth, Cloud Computing Provider with High Profile Clients
Today, we will look at why we like Megaport shares (ASX:MP1) and take a look to see if the MP1 share price is worth buying. Megaport is a cloud service provider across 130 cities and 23 countries and a NaaS (Network-as-a-Service) pioneer. With the advent of COVID-19,...
City Chic Collective (ASX:CCX) is an Omnichannel Retailer Expanding into the US and UK
Today, we will look at why we like City Chic shares (ASX:CCX) and give our views on our CCX share price forecast. City Chic is a leading plus-size women’s clothing retailer with 801,000 active customers. We first looked at City Chic back in mid-September 2019 when the...
Origin Energy (ASX:ORG) is a High Yield Dividend Play with Growth Potential
Today, we will look at why we like Origin Shares (ASX:ORG) as a dividend play and some research on our origin share price forecast. Origin Energy (ASX:ORG) is a leading integrated energy company and Australia’s largest energy retailer by revenue size and customer...